Re-engineering lupus into a cancer killer Researchers have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Lupus is a chronic inflammatory disease that occurs when the immune system attacks its own organs, tissues, or joints.
Trial shows benefit of 'BRCA-targeting' drug in prostate cancer Men with prostate cancer benefit from treatment with the pioneering drug olaparib -- the first cancer drug to target inherited mutations -- according to the results of a major trial.
Technology could let women skip annual mammograms Developing technology is on track to predict if and when breast cancer will appear. "We're creating a breast cancer risk analysis system," said an electrical engineer on the study. "It will be able to inform doctors about the patient's risk of developing cancer within a few years."
Cancer drug shows promise as cure for hepatitis B A potential cure for hepatitis B virus infections has been found with a promising new treatment proving 100 percent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials.